The Contribution of cocoa additive to cigarette smoking addiction
The Contribution of cocoa additive to cigarette smoking addiction
The Contribution of cocoa additive to cigarette smoking addiction
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Page 138 <strong>of</strong> 207 RIVM report 650270002<br />
Tyramine<br />
(4) <strong>The</strong> Hazardous Substances Data Bank (HSDB). HSDB, 1-1-2001. Electronic<br />
version.<br />
(5) Sjoerdsma A, Engelman K. Method for diagnosing phaechromocy<strong>to</strong>ma.<br />
United States Patents Office, 1968; pat. nr. 3.373.081.<br />
(6) D.D.Songstad, W.G.Kurz, C.L.Nessler. Tyramine accumulation in nicotiana<br />
tabacum transformed with a chimeric tryp<strong>to</strong>phan decarboxylase gene.<br />
Phy<strong>to</strong>chemistry, 1991; 30(10):3245-3246.<br />
(7) Roemer E, Hackenberg U. Mouse skin bioassay <strong>of</strong> smoke condensates from<br />
<strong>cigarette</strong>s containing different levels <strong>of</strong> <strong>cocoa</strong>. Food Addit Contam, 1990;<br />
7(4):563-569.<br />
(8) Hurst WJ, Martin RA, Zoumas BL, Tarka SM. Biogenic amines in chocolate -<br />
a review. Nutrition Reports International, 1982; 26(6):1081-1086.<br />
(9) Gajewska R, Lipka E, Ganowiak Z. Poziom histaminy i tyraminy w<br />
wybranych srodkach spozywczych. [Histamine and tyramine levels in selected<br />
food products]. Rocz Panstw Zakl Hig, 1991; 42(1):1-7.<br />
(10) Hannah P, Glover V, Sandler M. Tyramine in wine and beer. Lancet, 1988;<br />
1(8590):879.<br />
(11) A.R.Shalaby. Significance <strong>of</strong> biogenic amines <strong>to</strong> food safety and human<br />
health. Food Research International 1996; 29(7):675-690.<br />
(12) Huebert ND, Dulery BD, Schoun J, Schwach V, Hinze C, Haegele KD.<br />
Kinetics and metabolism <strong>of</strong> p-tyramine during monoamine oxidase inhibition<br />
by m<strong>of</strong>egiline. Clinical Pharmacology and <strong>The</strong>rapeutics, 1994; 56(nov):537-<br />
542.<br />
(13) Faraj BA, Bowen PA, Isaacs JW, Rudman D. Hypertyraminemia in cirrhotic<br />
patients. <strong>The</strong> New England journal <strong>of</strong> medicine, 1976; 294(25):1360-1364.<br />
(14) Schafers RF, Poller U, Ponicke K, Geissler M, Daul AE, Michel MC et al.<br />
Influence <strong>of</strong> adrenocep<strong>to</strong>r and muscarinic recep<strong>to</strong>r blockade on the<br />
cardiovascular effects <strong>of</strong> exogenous noradrenaline and <strong>of</strong> endogenous<br />
noradrenaline released by infused tyramine. Naunyn Schmiedebergs Archives<br />
<strong>of</strong> Pharmacology, 1997; 355(2):239-249.<br />
(15) Goodman and Gilman. 8 ed. Newyork, Pergamon Press, 1990. 8 ed. New<br />
York, Pergamon Press, 1990.<br />
(16) Poller U, Schafers RF, Schmuck S, Jakubetz J, Radke J, Daul AE et al.<br />
Influence <strong>of</strong> atropine on the cardiovascular effects <strong>of</strong> noradrenaline and<br />
tyramine in elder volunteers. Naunyn Schmiedebergs Arch Pharmacol, 1997;<br />
356(1):100-106.<br />
(17) Scriven AJ, Brown MJ, Murphy MB, Dollery CT. Changes in blood pressure<br />
and plasma catecholamines caused by tyramine and cold exposure. J
Change language